The Dow Jones Industrial Average plunged through the psychologically important 16,000 mark in yesterday’s sell-off, while the S&P 500 and Nasdaq slid 2% and 2.3%, respectively. But in Japan, a Lunar New Year’s treat for investors: The ever-volatile Nikkei 225 snapped a four-day losing streak to end up 1%. That’s performance that most American investors would kill for right…
Yesterday, shares of Biocryst Pharmaceuticals (BCRX) tumbled by 71% after the company had announced that the phase 2 trial failed to produce statistically significant results. The phase 2 trial, known as the OPuS-2 trial, tested the company’s drug BCX4161 — avoralstat — compared to a placebo compound. A total of 108 patients were recruited for…
After a day to forget for the European and US stocks which saw major indices in Europe lose more than 3% and US more than 1.8%, the Asian markets followed in the same path. Japans Nikkei is down 5.41% at time of writing, as the anxiety over slowing growth, falling oil prices (again below $30)…
After a meltdown in Asia, the global capital markets are stabilizing in Europe. The US S&P managed to recoup about half of its losses before the close yesterday, but this gave not comfort to Japanese investors. The yen’s strength and ongoing concerns about banks’ exposure to energy companies took the down 5.4% and pushed the 10-year…
Picking gold and silver equities in a stagnant price environment is a stock picker’s game that requires a particular thesis—and a fair portion of patience, says Joe Reagor, an analyst with ROTH Capital Partners. In this interview with The Gold Report, Reagor outlines types of companies he prefers and pairs those with names that patient investors…
The U.S. equities market is nearing recession status in 2016, with the S&P 500 down 8% on the year and the Dow Jones Industrial Average and the Nasdaq following suit with 7% and 12.87% declines, respectively. Jobs data Friday’s U.S. jobs report didn’t help either. According to the report, the United States added 151,000 jobs in…
A cloud of uncertainty has engulfed the financial markets as investors the world over have to deal with global macroeconomic challenges led by the China downturn and falling oil prices. The NYSE ARCA Biotech Index (^BTK) and NASDAQ Biotechnology Index (^NBI) have plunged 26.1% and 21.8% respectively so far this year. The second half of…
After beating the Zacks Consensus Estimate for seven consecutive quarters, Twenty-First Century Fox, Inc. (FOXA – Analyst Report) reported in-line earnings of 44 cents a share in the second quarter of fiscal 2016. However, quarterly earnings declined 17% year over year, disappointing investors. This was clearly reflected in the after-market trading hours yesterday, when shares tumbled 4.4%.
From omnipotence to impotence… Peter Pan(ic) is here… NKY is 1000 points below pre-NIRP levels and USD/JPY is 4 handles lower (JPY stronger)… Simply put – not only are words not enough to create the only effect that Central Banks care about, but their actions are now worse than doing nothing… Japanese Bank stocks are down 25% since…
Yesterday’s Trading: A fall in the oil and stock indices has facilitated a fall in the dollar/yen to 114.20 and a rise of gold to $1,200 per troy ounce. The euro has strengthened against the dollar to 1.1215. The rate rose to 1.1237 in Asia. The markets are closed for a week in China. Falling…
